|
FREE patent keyword monitoring and additional FREE benefits. |
|
|
Chemistry: Molecular Biology And Microbiology > Micro-organism, Per Se (e.g., Protozoa, Etc.); Compositions Thereof; Proces Of Propagating, Maintaining Or Preserving Micro-organisms Or Compositions Thereof; Process Of Preparing Or Isolating A Composition Containing A Micro-organism; Culture Media Therefor > Bacteria Or Actinomycetales; Media Therefor > Transformants (e.g., Recombinant Dna Or Vector Or Foreign Or Exogenous Gene Containing, Fused Bacteria, Etc.) Transformants (e.g., Recombinant Dna Or Vector Or Foreign Or Exogenous Gene Containing, Fused Bacteria, Etc.)Transformants (e.g., Recombinant Dna Or Vector Or Foreign Or Exogenous Gene Containing, Fused Bacteria, Etc.) patent applications listed are from June 2005 to current and include Date, Patent Application Number, Patent Title, Patent Abstract summary and are linked to the corresponding patent application page.01/25/07 - 20070020746 - Staphylococcus aureus polynucleotides and sequences The present invention provides polynucleotide sequences of the genome of Staphylococcus aureus, polypeptide sequences encoded by the polynucleotide sequences, corresponding polynucleotides and polypeptides, vectors and hosts comprising the polynucleotides, and assays and other uses thereof. The present invention further provides polynucleotide and polypeptide sequence information stored on computer readable media, ... 12/07/06 - 20060275886 - Dry powder cells and cell culture reagents and methods of production thereof The present invention relates generally to nutritive (e.g., cell culture) medium, medium supplement, media subgroup and buffer formulations. Specifically, the present invention provides powdered nutritive medium, medium supplement and medium subgroup formulations, particularly cell culture medium supplements (including powdered sera such as powdered fetal bovine serum (FBS)), medium subgroup formulations ... 07/13/06 - 20060154354 - High yield pertussis vaccine production strain and method for making same The present invention provides a vaccine production strain of Bordetella bronchiseptica that produces a pertussis toxin in high yield. The present invention provides a method for creating a Bordetella bronchiseptica cell line which produces a Bordetella pertussis toxin comprising the steps of introducing a plasmid containing a DNA encoding antibiotic ... 05/11/06 - 20060099701 - Activators of cyclin-dependent kinases A new gene family involved in cell cycle regulation was discovered. This family has been termed activators of cyclin-dependent kinases (ACDKs). A number of ACDK genes have been cloned and sequenced. Proteins encoded by ACDK genes specifically were shown to interact with CDKs and pRb, and to upregulate the kinase ... 04/20/06 - 20060084164 - Process for partitioning of proteins The present invention relates to isolation and purification of protein in aqueous two-phase systems (ATPS). Specifically, the invention provides processes for partitioning of proteins of interest in ATPS by fusing said proteins to targeting proteins which have the ability of carrying said protein into one of the phases. ... 03/30/06 - 20060068485 - Novel human synaptotagmin and polynucleotides encoding the same Novel human polynucleotide and polypeptide sequences are disclosed that can be used in therapeutic, diagnostic, and pharmacogenomic applications. ... 03/16/06 - 20060057703 - Method for the evaluation of implantable materials A method for the evaluation of a material to determine whether the material is susceptible to bacterial contamination or colonization comprising providing bacteria which are modified to produce a first detectable signal, exposing the material being evaluated to the bacteria and determining whether the first signal is present determining whether ... 03/16/06 - 20060057702 - Antibodies directed against amyloid-beta peptide and methods using same Monoclonal antibody 9TL and antibodies derived from 9TL directed against amyloid-beta peptide and methods of using same for diagnosing and treatment of Alzheimer's disease and Aβ peptide associated diseases are described. Methods of using antibodies directed against amyloid-beta peptide having impaired effector function for treatment of Alzheimer's disease and Aβ ... 03/16/06 - 20060057701 - Antibodies directed against amyloid-beta peptide and methods using same Monoclonal antibody 9TL and antibodies derived from 9TL directed against amyloid-beta peptide and methods of using same for diagnosing and treatment of Alzheimer's disease and Aβ peptide associated diseases are described. Methods of using antibodies directed against amyloid-beta peptide having impaired effector function for treatment of Alzheimer's disease and Aβ ... 03/16/06 - 20060057700 - Compositions and methods for eliciting an immune response to gram-negative bacterial infections Compositions for eliciting an immune response against Gram-negative bacterial infections and methods of making such compositions are provided. The composition comprises glycosylated pilin, the pilin being glycosylated with the O-antigen of a target Gram-negative bacteria of interest. Methods of eliciting an immune response by administration of such compositions are also ... 03/16/06 - 20060057699 - Culturing anaplasma The invention provides mammalian cells stably infected with Anaplasma species, as well as materials and methods related to propagating Anaplasma species in mammalian cells and isolating such Anaplasma species from mammalian cells. ... 02/16/06 - 20060035366 - Transglutaminase-producing strain It is intended to provide a strain capable of producing transglutaminase at a high efficiency; and a process for producing transglutaminase by using this strain. A structural gene from Streptomyces mobaraensis and a promoter and a terminator acting on this structural gene are externally transferred into Streptomyces mobaraensis to give ... 02/16/06 - 20060035365 - Method for identifying cellular growth inhibitors The present invention is a method which permits the selective screening for growth-inhibiting substances having a known mechanism of action; i.e., substances which inhibit or otherwise interfere with an enzyme or other gene product whose function is required for the growth or survival of the cell. The method employs cells ... 02/09/06 - 20060030022 - Compositions and methods for production of disulfide bond containing proteins in host cells The invention provides composition and methods for producing proteins of interest which comprise at least one disulfide bond, include proteins which in their mature form do not contain disulfide bonds, but whose precursor molecule contained at least one disulfide bond. The methods employ a host cell modified to more efficiently ... 01/26/06 - 20060019370 - Phage-resistant microorganisms and genetic determinants of phage resistance There are described new bacterial strains, plasmids derived thereof, a gene sequence included in the plasmids encoding a phage resistance system protein, and a method to confer phage resistance to microorganism cultures. ... 11/24/05 - 20050260736 - Selection of bacterial inner-membrane anchor polypeptides The invention overcomes the deficiencies of the prior art by providing a rapid approach for isolating polypeptides capable of anchoring heterologous polypeptides to a bacterial inner membrane. In the technique, libraries of candidate anchor polypeptides are expressed as fusions with a heterologous polypeptide that is capable of being detected when ... 11/24/05 - 20050260735 - Method of decomposing protein with sulfonic acid compound A method of assaying a glycated protein in a sample with the use of redox reaction, in which highly reliable measurement can be obtained. A sample containing a glycated protein is treated with protease in the presence of a sulfonic acid compound, so that the glycated protein is degraded. The ... 11/03/05 - 20050244943 - Cell concentration and pathogen recovery Methods and kits for the isolation of organisms. Such methods and kits are particularly useful for concentrating and recovering viable organisms from food material. The recovered organisms are of sufficient number and purity to allow detection using a biochip device. ... 10/06/05 - 20050221467 - Biological production of tetradehydrolycopene Mutant phytoene desaturase genes are provided encoding polypeptides having the ability to convert a phytoene desaturase substrate to tetradehydrolycopene. Both in vivo and in vitro methods are provided using the present phytoene desaturases for tetradehydrolycopene production. ... 10/06/05 - 20050221466 - Alanine 2,3,aminomutase Alanine 2,3-aminomutase sequences are disclosed, as are cells having alanine 2,3-aminomutase activity and methods of selecting for such cells. Methods for producing beta-alanine, pantothenate, 3-hydroxypropionic acid, as well as other organic compounds, are disclosed. ... 07/21/05 - 20050158842 - Microorganisms and assays for the identification of antibiotics The present invention features methods for the identification of compounds and compositions useful as antibiotics and antibacterial agents. In particular, the invention features methods for the identification of modulators of a previously unidentified target protein, termed CoaX. High-throughput assay systems are featured as well as assay kits for the identification ... 07/21/05 - 20050158841 - Osmotic actuator and engine The invention relates to an actuator for arrangement in contact with a biological solvent, comprising a housing (12) with a wall which is permeable to the solvent and not permeable to a first solute and which contains micro-organisms for transforming a second solute into the first solute and further comprising ... 07/14/05 - 20050153422 - Novel pseudonocardia sp. rmrc pah4 and a process for bioconverting compactin into pravastatin using the same The invention provides a novel microorganism Pseudonocardia sp. RMRC PAH4 characterized in that it is able to degrade high concentration of quinoline by enrichment culture, shows a high tolerance to compactin-sodium and possesses a high hydroxylation activity of converting compactin-sodium to pravastatin-sodium. The invention relates also a process for converting ... 07/14/05 - 20050153421 - Aqueous acrylamide solution containing saccharide This invention provides an aqueous solution of acrylamide that is useful as a starting material for high-quality polyacrylamide. Starting materials for polyacrylamide are an aqueous solution of acrylamide containing a saccharide and an aqueous solution of acrylamide containing a saccharide produced with the use of a biocatalyst having nitrile hydratase ... ### FreshPatents.com Support |